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CASE PRESENTATION 
A 34-year-old pregnant woman was referred to our 
emergency ward, complaining of intensification of 
skin lesions which had started six days earlier. 
Initially, vesicular lesions had started from head 
and face accompanied by fever which turn to 
generalized pustular lesions expanded to the whole 
body within four days (figure 1). By investigating 
the patient's personal contact history, we found 
that same symptoms were detected in her 9-year-
old child 19 days prior to admission which was 
diagnosed as chickenpox. The patient also had 
mentioned previous history of chicken pox 
infection at her age of seven. 
She was ill but not toxic and was conscious with a 
blood pressure of 98/59 mmHg, respiratory rate of 
18 breaths per minute, heart rate of 100 beats per 
minute and oral temperature of 37.2 °C in physical 
examination. She didn't have respiratory distress, 
dyspnea, meningism symptoms (Kernig Sign, 
Brudzinksi, and Nuchal Rigidity), ataxia or sensory 
defect and her all other physical examinations were 
normal. 
Upon diagnosis of chickenpox, intravenous (IV) 
acyclovir 750 mg three times a day and also IV 
clindamycin 900 mg TDS in combination with IV 
fluid were administered and finally the patient was 
admitted in Infectious diseases ward. 
LEARNING POINTS 
Varicella zoster virus (VZV) is an α herpes virus 
that commonly affect school-aged children in form 
of chicken pox and then it establishes latency in 
patient's dorsal root ganglia. A spectrum of signs 
and symptoms are represented from self-limiting 
in children to severe in immunocompromised 
patients. Probability of VZV infection in pregnant 
women is about one to five per 10000 pregnancies. 
Although the prevalence is not higher in pregnancy, 
but due to the special immune system of pregnant 
women, risks of maternal and fetal side effects are 
high due to the special immune system of pregnant 
women. VZV infection often manifests itself in form 
of shingles disease on reactivations, but it can 
prove to be reactivated with typical symptoms of 
chickenpox in very rare cases. It seems that history 
of VZV infection had been unable to cause a lifelong 
immunity for an individual and could not protect a 
person against recurrent chickenpox infection. To 
reduce high morbidity and mortality rate, 
physicians are advised to investigate a patient with 
diagnosis of chickenpox whenever a patient 
referred with generalized typical VZV lesions, 
despite history of previous exposure (1-3). 
All pregnant women with established chickenpox 
should receive antiviral therapy either alone or in 
combination with varicella zoster immune globulin 
(VZIG). Oral acyclovir is proper but IV acyclovir in 
severe pregnancy complications is preferred, 
especially in the second half of pregnancy. It is 
recommended to start antiviral therapy within 24 
hours and up to 72 hours of the development of 
rash (4). 
  
  
 
Figure 1: Patient’s skin lesions manifestations 
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Some believe that management could be 
considered based on immune testing instead of 
universal varicella-zoster immune globulin 
administration when dealing with presumed 
susceptible chickenpox exposed gravid (5). 
Susceptible pregnant women with significant VZV 
exposure should be offered VZIG. A history of 
chickenpox negates the need for serological testing. 
With no history of chickenpox, serology should be 
checked if time permits, otherwise, VZIG should be 
given. The main indication for VZIG is to modify 
disease and prevent maternal morbidity (4). 
Meanwhile, the patient should be monitored and 
treated by investigating the probable side effects 
that threaten the mother such as bacterial skin 
infection, varicella pneumonia and neurological 
complications (3). 
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